| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. (OTLK) has 10 insiders with recent SEC Form 4 filings, including 15 buys and 3 sells. OTLK is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.46M | $5.46M | +24.03M | |
| CEO | 800.0K | $1.26M | - | |
| Dir | 423.7K | $669.4K | +400.0K | |
| Dir | 286.7K | $453.0K | - | |
| Dir | 117.3K | $185.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Evanson Jeff64 | Chief Commercial Officer | Sell | 164,155 | $1.24 | $203,725.82 | -4.8% | -4.2% | -70.9% | |
| Oct 7, 2022 | Sukhtian Faisal Ghiath | Director | Buy | 30,000 | $1.29 | $38,700.00 | +78.9% | -18.3% | -81.9% | |
| Oct 7, 2022 | Haddadin Yezan Munther | Director | Buy | 33,343 | $1.29 | $42,940.47 | +37.2% | -18.3% | -81.9% | |
| Oct 5, 2022 | Hilzinger Kurt J | Director | Buy | 111,203 | $1.28 | $142,512.15 | +13.6% | -16.0% | -81.7% | |
| Oct 3, 2022 | Hilzinger Kurt J | Director | Buy | 88,797 | $1.24 | $110,500.24 | +10.1% | -15.3% | -80.8% | |
| Jun 21, 2022 | Trenary C Russell III49 | CEO And President | Buy | 19,925 | $1.06 | $21,120.50 | +56.9% | +20.0% | +66.7% | |
| Jun 21, 2022 | Dagnon Terry60 | Chief Operating Officer | Buy | 10,000 | $1.05 | $10,500.00 | +0.9% | +20.0% | +66.7% | |
| Mar 1, 2022 | Hilzinger Kurt J | Director | Buy | 27,708 | $1.69 | $46,826.52 | +11.3% | -31.5% | -35.7% | |
| Feb 28, 2022 | Hilzinger Kurt J | Director | Buy | 47,160 | $1.48 | $69,693.60 | +10.8% | -29.4% | -33.1% | |
| Feb 23, 2022 | Hilzinger Kurt J | Director | Buy | 175,132 | $1.47 | $256,969.93 | +123.5% | +6.4% | -17.4% |